University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Michael & Susan Dell Center for Healthy Living, Austin, TX, USA.
University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, TX, USA.
BMC Res Notes. 2023 Feb 10;16(1):13. doi: 10.1186/s13104-023-06280-8.
Food prescription programs are gaining interest from funders, policy makers, and healthcare payers as a way to provide value-based care. A small body of research suggests that such programs effectively impact health outcomes; however, the quality of existing studies is variable, and most studies use small samples. This study attempts to address these gaps by utilizing a quasi-experimental design with non-equivalent controls, to evaluate clinical outcomes among participants enrolled in a food prescription program implemented at scale.
We completed a secondary analysis of participant enrollment and utilization data collected between May 2018 and March 2021, by the Houston Food Bank as part of its multi-institution food prescription program. Enrollment data was obtained from 16 health care partners and redemption data from across 40 food pantries in Houston, Texas. Our objective was to assess if program participation impacted multiple cardio-metabolic markers. Exposure was defined as any visit to a food pantry after receipt of prescription. Linear and logistic regression models were used to estimate change in outcomes by exposure status and number of food pantry visits.
Exposed patients experienced a -0.28% (p = 0.007) greater change in HbA1c than unexposed patients, over six months. Differences across exposure categories were seen with systolic blood pressure (-3.2, p < 0.001) and diastolic blood pressure (-2.5, p = 0.028), over four months. The odds of any decline in HbA1c (OR = 1.06 per visit, p < 0.001) and clinically meaningful decline in HbA1c (OR = 1.04 per visit, p = 0.007) showed a linear association with visit frequency.
Our study of a large food prescription program involving multiple health care and food pantry sites provides robust evidence of a modest decline in HbA1c levels among participants. These results confirm that food prescription programs can continue to be effective at scale, and portend well for institutionalization of such programs.
作为提供基于价值的医疗服务的一种方式,食物处方项目正受到资助者、政策制定者和医疗保健支付者的关注。少量研究表明,此类项目能有效影响健康结果;然而,现有研究的质量参差不齐,且大多数研究采用小样本。本研究试图通过使用非等效对照的准实验设计来解决这些差距,以评估在大规模实施的食物处方项目中参与该项目的参与者的临床结果。
我们对 2018 年 5 月至 2021 年 3 月期间休斯顿食品银行(Houston Food Bank)作为其多机构食物处方项目的一部分收集的参与者登记和使用数据进行了二次分析。登记数据来自 16 个医疗保健合作伙伴,兑换数据来自德克萨斯州休斯顿的 40 个食品分发处。我们的目标是评估项目参与是否会影响多种心血管代谢标志物。暴露定义为收到处方后任何一次去食品分发处的访问。线性和逻辑回归模型用于根据暴露状况和去食品分发处的访问次数估计结果的变化。
在六个月的时间里,暴露组患者的糖化血红蛋白(HbA1c)变化比未暴露组患者大 -0.28%(p=0.007)。在四个月的时间里,收缩压(-3.2,p<0.001)和舒张压(-2.5,p=0.028)方面,暴露组之间存在差异。HbA1c 任何下降的几率(OR=每次就诊增加 1.06,p<0.001)和 HbA1c 有临床意义的下降几率(OR=每次就诊增加 1.04,p=0.007)与就诊频率呈线性关系。
我们对涉及多个医疗保健和食品分发处的大型食物处方项目的研究提供了有力证据,证明参与者的 HbA1c 水平有适度下降。这些结果证实,食物处方项目在大规模实施时仍然有效,并预示着此类项目的制度化前景良好。